FDA reform requires cultural change, not new legislation, Allergan's Herbert suggests.
This article was originally published in The Gray Sheet
Executive Summary
CONGRESSIONAL PRESSURE, RATHER THAN LEGISLATION, IS BEST ROUTE TO FDA REFORM, Allergan Chairman Gavin Herbert suggested at a May 2 Capitol Hill briefing sponsored by the California Health Care Institute (CHI). "Frankly, I am not sure we need a new law," Herbert said. "What we need is...perhaps some feet held to the fire by various congressional staffs to cause the agency to act in a more responsible way."